Osimertinib mesylate (AZD-9291 mesylate) is an EGFR third-generation inhibitor that inhibits the T790M resistance mutation produced by second-generation EGFR inhibitors with irreversible and oral activity. Osimertinib mesylate has antitumor activity for the treatment of EGFR-mutated non-small-cell lung cancer.
Molecular Weight:
595.71
Purity:
98.65%
CAS Number:
[1421373-66-1]
Formula:
C29H37N7O5S
Target:
EGFR
T3634
* VAT and and shipping costs not included. Errors and price changes excepted